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Abstract: Bluetongue virus (BTV) causes an economically important disease, bluetongue (BT),
in susceptible ruminants and is transmitted primarily by species of Culicoides biting midges (Diptera:
Ceratopogonidae). Since 2006, northern Europe has experienced multiple incursions of BTV through
a variety of routes of entry, including major outbreaks of strains of BTV serotype 8 (BTV-8) and
BTV serotype 1 (BTV-1), which overlapped in distribution within southern Europe. In this paper,
we examined the variation in response to coinfection with strains of BTV-1 and BTV-8 using an in vivo
transmission model involving Culicoides sonorensis, low passage virus strains, and sheep sourced
in the United Kingdom. In the study, four sheep were simultaneously infected using BTV-8 and
BTV-1 intrathoracically inoculated C. sonorensis and co-infections of all sheep with both strains were
established. However, there were significant variations in both the initiation and peak levels of virus
RNA detected throughout the experiment, as well as in the infection rates in the C. sonorensis that
were blood-fed on experimentally infected sheep at peak viremia. This is discussed in relation to the
potential for reassortment between these strains in the field and the policy implications for detection
of BTV strains.
Keywords: Arbovirus; Culicoides; Orbivirus; bluetongue; ruminant; infectious disease; transmission
1. Introduction
Bluetongue virus (BTV) is an arboviral pathogen mainly of ruminants and deer that is transmitted
primarily by biting midges of the genus Culicoides (Diptera: Ceratopogonidae) [1,2]. BTV is a member
of the genus Orbivirus within the family Reoviridae and its genome comprises 10 linear segments of
double-stranded RNA [3], which code for 7 structural and 4/5 non-structural proteins [4,5]. Currently,
at least 27 serotypes of BTV have been identified, based on the variability of the virus outer capsid
protein VP2 (encoded by genome segment 2), that exhibit only limited levels of cross protection
in the ruminant host [6–9]. In endemic regions, simultaneous infections can frequently occur with
multiple BTV strains and/or serotypes in a single host. In some areas, there is also an increased
frequency of these events due to the use of live attenuated vaccine strains that can be transmitted by
Culicoides [10–12]. These multiple infections may lead to a high rate of reassortment in the field and
recent laboratory-based studies have also demonstrated few apparent constraints on the process of
BTV genome segment exchange [13,14].
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Since 2006, BTV has caused widespread and economically damaging outbreaks of bluetongue
(BT) that have had a significant impact on sheep and cattle production across the Western Palearctic
region, through both clinical disease and movement restrictions imposed at a regional and national
level to control BTV spread [2,15]. While technologies to produce safe and efficacious inactivated
vaccines are available to reduce the impact of BTV outbreaks in northern Europe [16,17], the emergence
and re-emergence of strains presents an issue in terms of the proportionate policy response, as the
pathogenicity between strains of BTV in different breeds and species of hosts varies significantly [18,19].
This has led to difficulties in defining scenarios under which vaccination should or should not be
employed [20,21], both from the perspective of the impact of clinical disease and in reducing the
burden of trade restrictions between countries [22–25].
During the period 2006–2010, the most damaging outbreaks of BT were caused by a BTV serotype
8 (BTV-8) strain, which entered northern Europe directly via an unspecified route from sub-Saharan
Africa [26], and a BTV serotype 1 (BTV-1) strain that spread through Morocco into Spain and then
into France [1,2]. Both BTV strains were eventually controlled through vaccination campaigns but
overlapped in distribution for a significant period of time during 2008–2009 in Spain and France.
Anecdotally, these BTV strains differed significantly in their phenotype, most notably in clinical
severity (BTV-8 causing significant clinical signs in cattle, which were absent in BTV-1 infection,
and BTV-1 having a more severe clinical impact than BTV-8 infection in sheep) and in the occurrence
of transplacental transmission in cattle (observed repeatedly in animals infected with BTV-8) [27–30].
This led to discussion around the policy implications of co-circulating BTV strains in northern Europe,
particularly where changes in the spread or pathogenicity of novel emerging strains of BTV had the
potential to occur.
A study carried out previously in Belgium examined the co-infection of calves with BTV-1 and
BTV-8 strains with a view to explore the potential for competitive exclusion of these strains [31]. Rather
than aim to examine the potential for reassortant strains to emerge in northern Europe, this study used
serotyping assays to define the likelihood of transmission of BTV-1 and BTV-8 from co-infected calves,
as this was a priority for informing predictions of strain spread and subsequent vaccination strategy.
While the initial in vivo experiment was confounded by a contaminating strain of BTV serotype 15,
a second study using needle-based inoculation demonstrated that BTV-8 replicated to potentially
transmissible levels in three calves, while BTV-1 was present only at the limit of detection of the
real-time reverse transcriptase polymerase chain reaction (rRT-PCR) assay used to quantify BTV RNA.
The quantities of BTV-8 RNA were significantly reduced in these animals when compared to those
infected with just the BTV-8 strain.
In our study, we revisited this earlier experiment, following the development of improved in vivo
models for the study of BTV infection. We used colony-derived Culicoides sonorensis, intrathoracically
(IT) inoculated with strains of BTV-1 and BTV-8, to co-infect four sheep with both viral strains
simultaneously. We then assessed the development of viral RNA of both strains using an rRT-PCR
assay that detected BTV segment 2 (which determines serotype). Following the development of viremia,
we then allowed further batches of uninfected C. sonorensis to blood feed on co-infected sheep and
examined the retention of the two serotypes in the insect host. The aim of the study was to examine
the variation in responses to co-infection in both the ruminant and insect host.
2. Materials and Methods
2.1. Viruses, Vectors, and Hosts Used during Trials
2.1.1. Viruses
Two BTV strains were used throughout the experiments. All isolations and passages were carried
out using a cell line established from embryos ofCulicoides sonorensis in the USA (KC:C. sonorensis) [32,33].
Cells were grown in Schneider’s insect cell medium (Lonza, Slough, UK) and supplemented with 1%
penicillin/streptomycin (Sigma-Aldrich, Dorset, UK), 1% Amphotericin B (Sigma-Aldrich, Dorset, UK),
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and 10% Gibco® heat-inactivated fetal calf serum (ThermoFisher Scientific, Waltham, MA, USA)
(‘growth media’). A BTV-8 strain (NET2006/06) was isolated from an infected sheep detected in The
Netherlands during 2006. Similarly, a BTV-1 strain (MOR2007/01) from an infected sheep detected in
Morocco was also isolated on the same cell line. Both viruses were subsequently passaged once on the
KC C. sonorensis cell line and used as a KC2 passage for vector infection. The titer was quantified using
a serial dilution 96-well endpoint titration assay on KC cells incubated for 7 days at 28 ◦C. Titer of the
progeny virus in the cell supernatants was determined using an indirect in-house antigen sandwich
enzyme-linked immunosorbent assay (ELISA) to detect the presence of virus in a serially diluted
titration of samples [34] and calculated using the method of Spearman and Kärber [35]. C. sonorensis
were intrathoracically (IT) inoculated using 0.2 µL of tissue culture supernatant of BTV-8 or BTV-1 at a
titer of 5.75–6 log10 TCID50/mL [34].
2.1.2. Vectors
Culicoides sonorensis used was the PIRB-s-3 strain, originally derived from the Sorona (AA) line
propagated in Denver, Colorado, USA [32]. All C. sonorensis utilized in the experiments had emerged
from pupae at least four days prior to use.
2.1.3. Hosts
Female adult Dorset Poll sheep (>2 years of age) originating in the UK were used in a group of
four animals during the trial, housed in a high containment animal facility at the Pirbright Institute
and fed twice a day with grain pellets and with ad libitum access to hay and water throughout the
experiment [29]. An uninfected ‘direct contact transmission control’ sheep was housed in the same
pen as the treatment animals. All animals were screened for BTV antibodies prior to use using a
commercial competitive anti-VP7 antibody ELISA (IDVet, Montpellier, France).
2.2. Detection of BTV and Typing
RNA extraction from blood samples containing ethylenediamine tetraacetic acid anticoagulant
and rRT-PCR was carried out as described previously [36]. To control for inter-plate variation between
independent extractions and rRT-PCR, several replicates (for a 96-well plate, a minimum of 5 replicates)
of BTV RNA extracted from positive sheep blood with a known rRT-PCR Cq value were included
on each extraction/rRT-PCR plate. The sample results of respective plates were only accepted if the
positive control samples were within 2 Cq values of the previously determined value. Initial detection
of BTV RNA was carried out using the rRT-PCR assay based on genome segment 1(Seg-1) detection as
previously described and used (termed here as the detection assay) [34,37]. Serotype identification
of BTV-1 and BTV-8 strains was conducted directly parallel to the BTV detection assay in potential
co-infected samples (sheep blood and orally blood-fed midges) using individual typing rRT-PCR
assays based on the BTV genome segment 2 (Seg-2) and quantified by the Cq value (termed typing
assays) [31]. As previously validated, the separate BTV-1 and BTV-8 typing rRT-PCR assays had the
same efficiency and analytical sensitivity [38]. The serotype specificity of the BTV-1/BTV-8 rRT-PCR
typing assays used was also confirmed against virus samples of the BTV-1 and BTV-8 strains used in
this study as well as additional closely related strains with no evidence of cross reaction.
2.3. Infection of Sheep
Techniques used to infect C. sonorensis with BTV have been described previously [34]. Briefly,
over 2000 C. sonorensis were intrathoracically (IT) inoculated with 0.2 µL of either the BTV-1 or BTV-8
strain using pulled glass capillary needles (Narishige, London, UK) and a microinjector with a manual
syringe driver (Sutter Instruments, California, USA). Inoculation was carried out under light CO2
anesthesia and surviving C. sonorensis were transferred to specific pill boxes separate for each BTV
strain used and incubated for 5 days at 25 ◦C. A total of 575 C. sonorensis survived the incubation period
and were used to infect the four sheep (designated sheep 1–4; an unexposed sheep was designated
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sheep 5 as a transmission control). The same pill boxes were used in which the C. sonorensis were
stored to reduce the requirement for further anaesthetization and no attempt was made to equalize the
numbers exposed to the sheep for each strain to avoid further insect mortality. The four sheep were
then restrained and two pill boxes containing BTV-8 NET 2006/06 (pot 1) and BTV-1 MOR 2007/01 (pot 2)
IT-inoculated C. sonorensis simultaneously placed on both inner thighs for a period of 10 min (Figure 1).
Following this exposure, pill boxes were returned to the laboratory, C. sonorensis anaesthetized, and the
fully disseminated BTV infection rate was quantified in those individual C. sonorensis that had taken a
blood meal using the same rRT-PCR assay (as serotypes were separated and known), as defined in a
previous study [34].
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Figure 1. Bluetongue virus (BTV) infection of sheep via blood feeding of infected Culicoides sonorensis.
C. sonorensis were infected with BTV by IT inoculation and following an incubation period of 5–6 days at
25 ◦C allowed to feed directly on the inner thigh of a sheep as described in the methodology. Each sheep
was simultaneously exposed to one pot containing C. sonorensis infected with BTV serotype 1 and one
pot containing C. sonorensis infected with BTV serotype 8 for 10 min. The sheep was placed onto its rear
and held in the sitting position (similar to the position adopted for shearing).
2.4. Monitoring of Sheep
Blood samples were taken from the jugular vein on the day before the experiment began (day 0)
and then on days 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 12, 14, and 16 following infection. Clinical signs of disease
and rectal temperature were recorded for each animal daily. A postmortem of all sheep was carried out
following euthanasia at 16 days post infection (dpi), or when individuals reached a humane endpoint
for the protocol. Blood samples taken in the first 10 days post infection were tested for their quantity of
viral RNA by rRT-PCR on the same day. Nucleic acid was extracted from 50 µL of the blood sample
and the quantity of viral RNA in the sample subsequently assessed by detection and typing rRT-PCR
assays. Preliminary data suggested that a blood sample with a rRT-PCR Cq value of less than 25 would
result in the animal reaching peak viremia within two days.
2.5. Clinical Score Calculation
A daily clinical score was recorded for each animal. The score was based on the following 11
criteria: 1. Red ess of eyes; 2. Redness of mucosal embranes (oral and nasal); 3. Facial edema;
4. Salivation; 5. Nasal discharge; 6. Cough; and 7. Ulcers (oral and/or nasal) nd were ll scored daily
from 0.5 (very mild) to 3 (sev re) (increments of 0.5 were used). 8. Temperature was incorporated into
the daily score as follows: The normal body emperature of each individual she p was determin
for at least 3 days prior to infection and the average body t mperature was used as the “baseline”.
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An increase of ≥1 ◦C from the baseline temperature incurred a clinical score of 1; ≥1.5 ◦C of 2 and ≥2 ◦C
of 3 for each day of occurrence. 9. A behavior score was included as follows: Apathy and slowness = 1;
reluctance to get up unaided and prolonged daily separation from the group = 2; reluctance to get up
in response to direct stimulation/body posture indicative of pain = 3 (immediate humane endpoint).
10. A food intake score was determined as follows: Reduced food intake = 1; avoiding concentrate
but eating hay = 2; no food intake = 3. The food intake was scored across two daily meals and then
averaged. 11. Clinical signs of BTV infection in feet was determined separately for each foot, ranging
from 0.5–3 and considering warmth, reddening, lesions, and lameness and subsequently averaged for
a daily foot score.
Sheep were euthanized if they reached pre-defined humane endpoints of moderate to high severity
limits defined within the study protocol in the ethics project license. These endpoints could be reached
either by severity of single behavioral or clinical signs or a combination of several signs of moderate
severity on a single day.
2.6. Pathology Score Calculation
The total gross pathology score was determined through a combination of a hemorrhage score,
an edema score, an ulceration score across a standardized range of selected organs, and a lung lesion
score; all criteria were marked from 0.5 (very mild) to 3 (severe).
2.7. Infection of Culicoides sonorensis
At peak viremia, pots of approximately 250 adult C. sonorensis were exposed to the inner thigh
of each sheep. Once returned to the laboratory, blood-fed females were selected under light CO2
anesthesia and incubated for 8 days at 25 ◦C. Those surviving this period were selected under CO2
anesthesia and placed individually in racked 96 sample polypropylene tubes (Qiagen, Crawley, UK).
A selected number of blood-fed females were also processed immediately following blood feeding
without incubation to obtain BTV RNA values of uptake only (D0 midges). Individual Culicoides were
then homogenized using a 3-mm stainless steel ball bearing (Dejay Distribution Ltd., UK) in 100 µL of
Schneider’s media (Sigma Aldrich, Poole, UK), before the addition of a further 900 µL of Schneider’s
media. Pools of 400 µL were then created in polypropylene tubes using 50 µL of homogenate
from each of 8 individuals and screened using the detection rtRT-PCR assay [37]. Where BTV was
detected, individual samples from that pool were retested using the detection rtRT-PCR assay and the
BTV-1/BTV-8 typing rtRT-PCR assays, as for sheep blood [38].
2.8. Statistical Analysis
Levels of viral RNA (Cq values) in sheep determined by the three rtRT-PCRs (i.e., segment-1
(detection), BTV-1, and BTV-8 segment-2 (typing)) were compared using a linear mixed model with Cq
as the response variable, days post exposure and assay and an interaction between them as fixed effects,
and sheep as a random effect. Model selection proceeded by stepwise deletion of non-significant
(p > 0.05) terms (judged by likelihood ratio tests), starting from a model including all explanatory
variables. The proportion of C. sonorensis positive for viral RNA of each BTV strain after incubation
was analyzed using a binomial family generalized linear model with a logit link function, with the
proportion of positive midges as the response variable and the virus strain (BTV-1 or BTV-8) and
blood meal Cq value as explanatory variables. Model selection proceeded by stepwise deletion of
non-significant (p > 0.05) terms (judged by likelihood ratio tests), starting from a model including all
explanatory variables. All analyses were implemented in R (version 3.6.1) [39].
2.9. Ethics Statement
All animal experiments were carried out in accordance with the UK Animal Scientific Procedure
Act (ASPA) 1986, which transposes European Directive 2010/63/EU into UK national law. All animal
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experiments were conducted in compliance with a national project license number PPL 70/7819 granted
by the UK Home Office to Dr Karin Darpel from 1st September 2013 to 1st September 2018.
3. Results
3.1. Infection of Sheep
A total of 575 C. sonorensis that survived the extrinsic incubation period following IT inoculation
were exposed to the sheep (Table 1; Supplementary Table S1). In total, 100 of the 575 C. sonorensis
took at least a partial blood meal (17% of those exposed), of which 97 produced Cq values (using the
detection rRT-PCR assay) indicative of full dissemination (≤ 25) [34]. In total, 57 of these fully infected
C. sonorensis were infected with BTV-1 and 40 were infected with BTV-8 and the proportions feeding on
each sheep are shown in Table 1 (Supplementary Table S1).
Table 1. Number of intrathoracically (IT) inoculated Culicoides sonorensis blood fed on sheep.
Each C. sonorensis was inoculated with either a bluetongue virus serotype 1 (BTV-1) or BTV-8 strain and
then incubated in pill boxes at 25 ◦C for five days prior to feeding on sheep.
Sheep
Number
Total Inoculated
Culicoides Exposed
Culicoides Fully
Engorged
Culicoides Partially
Engorged
Total Blood Fed
(% Total Exposed)
Number ≤ 25 Cq *
(% Total Blood-Fed
on Sheep)
BTV-1 MOR2007/01 1 50 12 5 17 (34) 16 (52)
BTV-8 NET2006/06 1 59 11 4 15 (25) 15 (48)
BTV-1 MOR2007/01 2 71 1 4 5 (7) 5 (33)
BTV-8 NET2006/06 2 68 5 5 10 (15) 10 (67)
BTV-1 MOR2007/01 3 58 14 1 15 (26) 13 (68)
BTV-8 NET2006/06 3 84 5 1 6 (7) 6 (32)
BTV-1 MOR2007/01 4 112 16 7 23 (21) 23 (72)
BTV-8 NET2006/06 4 73 3 6 9 (12) 9 (28)
Total - 575 67 33 100 (17) -
* rRT-PCR Cq value ≤ 25 indicates C. sonorensis containing a fully disseminated infection with bluetongue virus [27].
3.2. Monitoring of Sheep
Levels of BTV RNA indicative of viremia were demonstrated for all four sheep, although the
peak level of viremia in sheep 4 was reduced (Figure 2; Supplementary Table S2). Cq values did not
differ significantly (p = 0.97) between the detection and typing for BTV-1 assays but were significantly
(p < 0.001) lower for the typing for the BTV-8 assay compared with the other two assays (estimated
difference in Cq values (95% confidence interval (CI): Typing BTV-8 vs. detection = 5.5 (4.1–7.0); typing
BTV-8 vs. typing BTV-1 = 5.4 (3.9–6.8)) (Figure 2). This difference was consistent across time points
(i.e., there was no significant (p = 0.16) interaction between days post exposure and assay).
In all cases, BTV-1 segment-2 RNA was detected in greater quantities from sheep during the viremic
period, including in sheep 2 where a greater number of IT inoculated C. sonorensis transmitting BTV-8
(5 fully fed; 5 partially fed) were successfully fed than those transmitting BTV-1 (1 fully fed; 4 partially
fed). No BTV RNA was detected in the blood of the transmission control sheep 5, which remained
negative for BTV RNA throughout the entire course of the study.
3.3. Clinical Scores
All BTV-infected sheep developed classical clinical signs of BTV infection, including reddening of
the eyes and mucosal membranes and facial edema. Clinical signs were first recorded at 5 dpi and
daily clinical scores were determined for each individual from this day onwards (Figure 3). Two sheep
(sheep 1 and 3) were euthanized on 7 dpi due to apathy and reluctance to get up, as well as cessation
of food intake and a more pronounced appearance of several other visible clinical signs (Figure 4).
The remaining two sheep, 2 and 4, experienced moderate clinical signs characterized by small petechial
ulcerations on the nose/muzzle and redness and inflammation of the feet later in infection (11–16 dpi)
(Figures 3 and 4). No clinical signs were recorded in the transmission control sheep 5 at any time
during the study.
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Figure 3. Daily clinical score of sheep co-infected with two BTV strains. The daily cumulative score
across 11 clinical criteria are shown for each sheep (S1–S4). Clinical progression was markedly more
rapid and severe in sheep 1 and 3 and the total clinical score accumulated on a single day was a
clear indicator for overall severity requiring euthanasia (*). Sheep 2 and 4 also developed disease of
overall moderate severity, but this was more reflected in the duration and chronic manifestation (ulcers,
feet pathology) without affecting any behavior or feeding responses.
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Figure 4. Clinical anifestation of BTV co-infection in Dorset Poll sheep. All four sheep developed
typical clinical signs indicative of BTV infection, such as reddening of the eyes and mucosal membranes,
facial edema, nasal discharge, and salivation. However, clinical progression was quicker and more
pronounced in sheep 1 and 3 (e.g., Panel A, sheep 3) and both sheep were euthanized at 7 dpi on
reaching the humane endpoints of the study protocol. Sheep 2 and 4 developed moderate clinical
BT (e.g., panel B sheep 2) and developed more chronic disease features, such as ulcers and petechial
bleeding of the nostrils, later in infection (12–16 dpi).
3.4. Pathology Scores
Gross-pathological changes were recorded at necropsy of all four infected sheep. The acute
oedemic and hemorrhagic scores were higher in those two sheep euthanized during the acute phase
of the disease at 7 dpi (sheep 1 and 3), although hemorrhagic lesions of selected lymph nodes were
still present at 16 dpi (Table 2 and Figure 5). Both sheep reaching the study end of 16 dpi (sheep 2
and 4) had evidence of pathological changes, with sheep 2 in particular demonstrating clinical signs
associated with BT, such as a hemorrhage of the tongue and pulmonary artery (Table 2 and Figure 5).
Table 2. Pathology score of all sheep at time point of euthanasia. Sheep 1 and 3 were euthanized as they
exceeded clinical limits for the study at day 7 post-infection with bluetongue virus (BTV). Clinical signs
exhibited by sheep 2 and 4 were observed to the end of the study (day 16 post infection with BTV).
Sheep 1 Sheep 2 Sheep 3 Sheep 4
Day of necropsy 7 dpi End of Study 7 dpi End of Study
Clinical Scoring
Edema 2 0 2 0
Face 2 0 2 0
Body 0 0 0 0
Lung 0 0 0 0
Body cavities 0 0 0 0
Hemorrhage 12 10 14 6
Lymph nodes (Pre-scapular + Pharyngeal + Femoral) + tonsil 1 + 3 + 0 + 3 2 + 2 + 0 + 2 2 + 3 + 0 + 3 1 + 3 + 0 + 2
Mucosal membranes 3 1 3 0
Tongue 2 1 3 0
Muscles and subcutaneous 0 0 0 0
Heart vessels 0 2 0 0
Ulcer 4 2 1 3
Mouth/Nose 2 2 (mouth and nose 1) 1 2
Feet 2 0 0 1
Pneumonia 0 0 0 0
Total Score 18 12 17 9
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Figure 5. Hemorrhages observed across different organs in BTV co-infected sheep. BTV-specific
pathological features observed in sheep 1 and 3 euthanized at day 7 post-infection included hemorrhages,
petechial bleeding, and ulceration in the oral mucosa membrane (A), tongue (B), pre-scapular lymph
node (C), and pulmonary artery (D).
3.5. Infection of Culicoides sonorensis
A total of 688 C. sonorensis were fed on the sheep and then survived the extrinsic incubation period
(Table 3). None of the C. sonorensis exposed to sheep 1 at 6 dpi imbibed a blood meal, hence no data on
viral uptake and/or replication could be obtained for this time point (Table 3). In total, 22 C. sonorensis
contained BTV RNA at 8 days following feeding on the infected sheep (Table 3; Supplementary
Table S3). Feeding on sheep 3 produced 14 infections in C. sonorensis (11 with Cq ≤ 25; and 3 Cq ≥ 25 in
the detection assay: 5.6% containing RNA in those exposed); on sheep 4, 2 infections; and on sheep 1,
6 infections (6 Cq ≤ 25: 5.1%), while no C. sonorensis became infected from feeding on sheep 2. BTV-1
Seg-2 RNA was detected in all positive C. sonorensis fed on sheep 3 and 1, and a single individual fed
on sheep 1 possessed a mixed BTV-1/BTV-8 infection (typing BTV-1 Cq: 20.75; typing BTV-8 Cq: 33.79).
BTV-8 Seg-2 RNA only was detected in C. sonorensis fed on sheep 4.
Assuming C. sonorensis were infected if they had any Cq value, there was no significant difference
in the proportion of positive individuals between strains (p = 0.27). There was, however, a significant
increase in the probability of C. sonorensis containing detectable BTV RNA following incubation with a
decrease in the Cq value of the blood on which it originally fed (odds ratio (OR): 0.77, 95% confidence
interval (CI): 0.70–0.86, p < 0.001). If blood meal Cq was not included as a factor in the analysis,
there was a significantly higher proportion of C. sonorensis positive for the BTV-1 strain compared with
the BTV-8 strain (OR for BTV-8 compared with BTV-1: 0.14, 95% CI: 0.04–0.49, p < 0.001). This suggests
that the difference in the proportion of positive C. sonorensis for each strain is a consequence of higher
levels of virus possessing a segment 2 sequence corresponding with BTV-1 than those corresponding
to BTV-8 (Table 3). These conclusions remain the same if C. sonorensis were assumed to be positive only
if they had a Cq value < 25.
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Table 3. Culicoides sonorensis blood feeding on sheep co-infected with BTV-1 and BTV-8. C. sonorensis were fed at day 6 and day 7 post infection of sheep with
bluetongue virus and then stored for 8 days at 25 ◦C prior to processing.
Sheep (Day) Sheep BTV DetectionAssay Cq
Sheep BTV-1
Typing Assay Cq
Sheep BTV-8
Typing Assay Cq
Sheep Virus ISOLATION
(Log10TCID50)
Culicoides sonorensis (n)
Fed on Sheep
C. sonorensis Positive on
Detection Assay (% total)
Following 8-Day Incubation *
Positive C. sonorensis BTV
Typing Assays for BTV-1; BTV-8
1 (6) 17.49 17.87 27.37 - - - -
1 (7) 17.07 17.48 28.47 5.75 88 6 (6.8); 6 5 BTV-1; 1 BTV-1 +BTV-8
2 (6) 24.08 24.61 28.47 0 80 0 0
2 (7) 17.56 17.11 29.72 6.0 32 0 0
3 (6) 19.51 19.72 30.49 6.0 112 7 (6.2); 6 All BTV-1
3 (7) 20.97 19.15 34.36 5.0 96 7 (7.3); 5 All BTV-1
4 (6) 24.93 25.75 29.75 0 176 0 0
4 (7) 27.10 26.53 32.36 0 104 2 (1.9); 0 All BTV-8
* rRT-PCR Cq value ≤25 indicates C. sonorensis fully disseminated infection [27].
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4. Discussion
In this paper, we used a C. sonorensis BTV sheep infection model to explore transmission of BTV-1
and BTV-8 strains that co-circulated during the early stages of BTV incursions in northern Europe.
In a previous study in which calves were co-infected with BTV-1 and BTV-8 strains using needles,
high BTV-8 viremia was detected [31]. In contrast, in our study, using a natural infection and sheep
host model resulted in viruses of serotype 1 predominating within all four sheep tested. This even
occurred in the case of sheep 2, where more C. sonorensis fully infected with BTV-8 were fed to repletion
on the sheep than those that were infected with BTV-1. The study also demonstrates that strains of
serotype 8 can be recovered in C. sonorensis fed on co-infected animals despite relatively low levels of
RNA of this serotype being present within the sheep. Finally, one C. sonorensis from a total of 22 that
developed infections from feeding on viremic sheep developed a mixed infection of BTV-1 and BTV-8,
indicating the potential for strains to co-infect the insect host as proposed in studies previously [40].
Intrathoracic infection of C. sonorensis using both BTV-1 and BTV-8 consistently led to fully
disseminated infections as inferred through the use of rRT-PCR Cq values [34]. Successful feeding of
infected C. sonorensis on the sheep following IT inoculation and incubation is not certain and hence
is not standardized. Relatively large numbers of C. sonorensis were therefore exposed to the sheep,
with numbers successfully feeding ranging from 5 to 23 individuals for infection with either BTV-8 or
BTV-1. While the number of Culicoides infected with BTV blood feeding on sheep in the field has not
been assessed, their populations and subsequent biting rates are among the highest in hematophagous
insects [41–44]. All sheep were successfully simultaneously infected with both strains of BTV through
the feeding of C. sonorensis with fully disseminated infections, illustrating the high rates of transmission
obtained via this route [45,46].
Bluetongue virus RNA was first detected in sheep 1, 3, and 4 on day two post infection (Figure 2).
In contrast, RNA was only detected on day 4 post infection in sheep 2 (Figure 2). Similarly, sheep 2
also reached peak BTV RNA levels in blood on day 7 post infection, later than observed in sheep 1
(day 5), sheep 3 (day 5), and sheep 4 (day 3). Sheep 2 was fed on by fewer fully infected C. sonorensis
(15) than sheep 1 (32), sheep 3 (21), and sheep 4 (32), and this lower rate of inoculation may have led to
this delayed onset of RNA detection as demonstrated in a previous study [45].
Co-infection with BTV-1 and BTV-8 was successfully established in all four sheep, despite sheep 2
only being exposed to one C. sonorensis infected with BTV-1 taking a full blood meal and four taking
partial blood meals. In all four sheep, BTV-1 Seg-2 RNA was detected in greater quantities than BTV-8
Seg-2 RNA at all time points using the BTV typing assays and was closely correlated with Seg-1
RNA detected using the BTV detection assay. There was no visible correlation between the numbers
of infected C. sonorensis feeding and the peak of RNAemia attained. In addition, the ratio between
C. sonorensis infected with each serotype feeding on the sheep did not seem to influence the levels of
viral RNA for the two strains of BTV.
Divergence in the levels of viral RNA, however, was recorded between sheep 1 and 3 when
compared to sheep 2 and 4, with the former experiencing a very high and sustained plateau of BTV-1
Seg-2 RNA levels at < 20 Cq and the latter only achieving this for a brief period of 1 day in sheep 2
and not at all in sheep 4. The drivers for differences in the levels of viral RNA were unclear and not
correlated either with differences in the number of infected C. sonorensis initially imbibing a blood meal
from the sheep, or a difference in the ratio between C. sonorensis infected with either BTV-1 or BTV-8
taking a blood meal. Both sheep 1 and 3 suffered significantly greater clinical signs than sheep 2 and 4
and this may have been due to the greater quantity of circulating BTV-1 with virus titers ranging 5 to 6
Log10TCID50 (Table 3). Studies using BTV-1 and BTV-8 strains of the same phylogenetic lineage as used
in the current study have reported an earlier onset of clinical disease in BTV-8-infected sheep, but with
the greatest severity observed in BTV-1-infected sheep (10–15 dpi). This observation was correlated
with an earlier rise in BTV-8 RNA levels but comparable BTV RNA generation detected in sheep with
either virus strain at peak infection [30]. Future studies could explore if the initial progression and
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initiation of viral RNA production (in combination with or independent of peak levels of BTV RNA
produced) is at least partially correlated to subsequent clinical disease progression [47].
The infection rates of C. sonorensis when fed on the sheep were low and similar to those obtained
during previous in vivo studies [45,48] and in epidemiologically relevant Culicoides species present in
northern Europe fed via membrane-based techniques in Switzerland [49] and pledglet-based methods in
the UK [50]. As expected, the likelihood of being able to detect the successful uptake of infectious virus
by blood feeding C. sonorensis (processed immediately after feeding without any further incubation)
was largely correlated with the amount of infectious viral particles circulating in the systemic blood of
the sheep on the day of feeding. In our experiments, the exception to this rule were three individuals
fed on sheep 2 at 7 dpi (sheep blood Cq value of 17.56); otherwise, all individual C. sonorensis feeding
on a sheep with ≤Cq21 resulted in a positive rRT-PCR detection of BTV RNA. It is currently unclear
why those individuals feeding on sheep 2 did not have detectable amounts of BTV RNA in their blood
meal; however, it is important to note that the viral presence in the skin periphery could differ from the
level detected systemically in blood samples taken at the jugular vein [51]. Low virus RNA levels were
occasionally also detected in individual C. sonorensis directly following blood feeding on sheep with
less viral RNA in the blood; however, detection was less consistent and at the detection limit of the
diagnostic rRT-PCR assay (Table 3 and Supplementary Material Tables S2 and S3).
Culicoides sonorensis fed on those sheep with the highest level of virus RNAemia also had the greatest
probability of developing infections (Table 3, sheep 1 and 3), and in the majority of individuals, BTV-1
replicated to levels previously indicative of fully transmissible infections (≤Cq25) [34]. Nonetheless,
it is interesting to note that in three individual midges, some degree of viral replication of BTV-8
occurred despite relatively low detected Seg-2 RNA levels (≤28Cq in the sheep at the time of feeding),
and in the absence of any detectable BTV-8 viral RNA uptake at day 0. Hence, the probability of
BTV replication within vector insects following blood feeding on infected sheep does not seem solely
explainable by viral levels detected in the systemic sheep blood at the time, although as only segment
2 RNA from BTV-8 was identified it is currently unknown if the virus might have reassorted within the
ruminant host.
A key aspect not addressed in the current study is the detection and potential impact of reassortment.
Reassortment of BTV can occur when two strains of the virus co-infect a single cell, either in the host or
vector. The BTV genome consists of 10 linear segments of double-stranded RNA, and in tissue culture,
these segments have been demonstrated to be exchanged with few constraints between European
strains of BTV serotype 1 (BTV-1) and BTV serotype 8 (BTV-8) [14]. Analysis of full genome sequences
from across European strains of BTV has highlighted that this phenomenon occurs frequently but may
also be subject to specific selective pressures that are not fully understood [13,52,53]. Reassortment of
BTV strains in the ruminant host were studied in vivo in the USA during the 1980s in both ruminants
and vectors [40,54,55]. These experiments highlighted differences in the rate of reassortment between
sheep (95% parental strains recovered and 5% reassortant) and a bull (11% parental strains and 89%
reassortant). In addition, mixed infection of colony-derived Culicoides sonorensis led to proportions of
reassortant progeny that varied between 7% and 78% in 8 reassortant-yielding flies. The current study
has demonstrated that BTV-1 and BTV-8 duel infections can occur in both the ruminant and insect host
and further studies are required to characterize this process.
The policy implications of the current study are significant in highlighting circulation of multiple
strains within the ruminant and vector hosts. It demonstrates the importance of serotype determination
and full genome characterization where there is doubt regarding the identity of circulating strains.
In the case of sheep 4, there was also demonstration that a strain of a serotype that was circulating only at
reduced levels of RNA within the ruminant host was transmitted to and replicated within C. sonorensis.
A key question arising from this observation is whether this represented a reassortant strain and at
what point in the cycle of infection this reassortment took place. The study highlights, however, that
simple extrapolation from Cq values to likely infection of Culicoides requires care, particularly in areas
where multiple serotypes and strains of BTV co-circulate.
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5. Conclusions
This experimental study has demonstrated that co-infection of bluetongue virus strains in sheep
can lead to a range of outcomes in onwards transmission from sheep by Culicoides biting midges.
We infected Culicoides biting midges with either BTV-1 or BTV-8 by injecting the virus into individuals
and then allowing it to replicate within the insect. Then, we used these fully infected Culicoides to infect
four sheep with both strains simultaneously. Both the clinical signs and the profile and peak level of
viral RNA developed in each sheep varied significantly across the sheep alongside clinical disease
signs to a greater degree than was expected. We then fed more unexposed Culicoides on the sheep to
assess infection rates. We found that both strains persisted in the host, in contrast to a previous study,
and that infection of Culicoides was dependent on being fed when the viruses were at present in the
sheep at sufficient levels and a dose-dependent relationship with the specific strain. These results
emphasize the importance of using a natural route of infection during BTV transmission experiments.
Supplementary Materials: The following are available online at http://www.mdpi.com/2076-2607/8/6/851/s1,
Table S1: Levels of bluetongue virus RNA (Cq) detected in intrathoracically inoculated Culicoides sonorensis
following incubation for 5 days at 25 ◦C and exposure to uninfected sheep. Table S2: Levels of bluetongue virus
RNA (Cq) detected in sheep following exposure to Culicoides sonorensis intrathoracically inoculated with either a
strain of BTV serotype 1 or serotype 8. Table S3: Feeding of uninfected Culicoides sonorensis on sheep infected with
bluetongue virus. Culicoides sonorensis successfully taking a blood meal were processed immediately following
feeding and following incubation for 8 days at 25 ◦C.
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